NCT05472662View on ClinicalTrials.gov

A Study to Compare the Effects of Two Propellants in Adults With Mild Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Asthma
Interventions
DRUG

Placebo 152a

Placebo pressurised metered-dose inhaler (pMDI) formulated with the 152a propellant

DRUG

Placebo 134a

Placebo pressurised metered-dose inhaler (pMDI) formulated with the 134a propellant

Trial Locations (1)

Unknown

Medicine Evaluation Unit Limited, Manchester

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY